Incyte Corp (INCY)
61.26
-0.82
(-1.32%)
USD |
NASDAQ |
Mar 26, 16:00
61.28
+0.02
(+0.03%)
After-Hours: 07:53
Incyte Price to Book Value: 3.439 for March 26, 2025
View 4,000+ Financial Data Types:
Add
Browse
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Eli Lilly and Co | 52.32 |
| Syndax Pharmaceuticals Inc | 3.920 |
| Exelixis Inc | 4.616 |
| Halozyme Therapeutics Inc | 21.60 |
| Regeneron Pharmaceuticals Inc | 2.384 |
Price to Book Value Related Metrics
| PE Ratio | 226.89 |
| PS Ratio | 3.062 |
| Price to Free Cash Flow | 55.23 |
| Price | 61.26 |
| Earnings Yield | 0.44% |
| Market Cap | 11.86B |
| Operating PE Ratio | 128.35 |
| Normalized PE Ratio | 1890.10 |